About Us

Research and Innovation are in our company’s DNA. They are what we stand for as a regenerative medicine company and continue to fuel us to develop more accessible, sustainable and ground-breaking solutions to address real clinical problems.

Innovations Based on Years of Research

Backed by years of research and development in stem cells and tissue engineering, we aim to harness the potential of proteins and cell signalling molecules produced by cells cultured under favourable conditions, to develop innovative biological materials and combination medical devices.

Our Partners

Cultivating the relationship with our partners is a cornerstone of our business. We make the commitment to understand the real needs of our customers through our trusted partners, who are also at the forefront of ground-breaking innovations. As Science and Technology advance, so do we. This is all so to generate better values and outcomes for both our partners and clients.

NUS

We are in collaboration with the National University of Singapore (NUS), Faculty of Engineering, Department of Chemical and Biomolecular Engineering to identify the essential and relevant extracellular matrix components derived from human fibroblast culture systems.

A*STAR

We have collaborations with several institutes from the Agency for Science, Technology and Research (Singapore, A*STAR), which include Bioprocessing Technology Institute (BTI) and Institute of Materials Research and Engineering (IMRE) to develop key processes for to-scale production of these cell-based proteins and bioactive molecules for a variety of applications ranging from acellular skin grafts to cosmeceutics and skin care.

NHG - CMTi

We are in talks with National Healthcare Group (NHG), Centre for Medical Technologies & Innovations (CMTi) to develop clinical applications of the cell culture-derived matrices to aid healing of chronic diabetic foot ulcers, venous leg ulcers and pressure wounds. This collaboration will involve experienced surgeons in the fields of trauma and geriatric medicine, who will provide first hand feedback in the development of this clinically relevant product.

eSG

We are proud to be part of the Enterprise Singapore (ESG) network and featured as a startup in the Startup SG portal, an initiative of ESG. This valuable collaboration helps our company gain access to the resources and network available from ESG, as we scale through deep tech and business developments.

SMU

As a member of the SMU-SCALE programme, we are part of a network with start-up Founders, SME Entrepreneurs and Business Leaders. With access to successful entrepreneurs, industry-experienced educators and distinguished researchers, we are privileged to tap on their experience, mentoring, strategy optimization, feedback and network.

SGTech

As part of a premier trade association for the tech industry in Singapore, we are happy to partner with SGTech in navigating through a rapidly evolving technology landscape. With SGTech, we are part of an ecosystem that focuses on nurturing the next generation of tech talents. With access to the Global Ready Talent Programme, an initiative of Enterprise Singapore, we are proud to play a part in providing opportunities for talent development in the local and overseas market.

Our Awards and Accolades

At Kent Ridge Labs, we pride ourselves as a Medtech company that harnesses the power of scientific innovations to redefine boundaries and improve lives.

As we continue to garner prestigious awards over the years, we are proud that the market and our peers recognise the strengths of our technology and our ability to deliver effective innovations to our customers.